Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet ores
operating since 1972
1095.73
Headquarter in Paris and 3 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

We have observed 4 EP applications Elsa Martin-Touaux has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305332

A mixture of polar glycolipids for use in the treatment of pain and COPD

IPC classification:
A61P 11/00, A61P 29/00, C12R 1/89, C12P 19/04, C08B 37/00, A61K 31/739, A61K 35/74
Applicant:
Sanofi, S.A.
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION WITHDRAWN
EP12305677

CHO expression system

IPC classification:
C12N 15/79, C12N 15/69
Applicant:
Sanofi, S.A.
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION WITHDRAWN
EP13843154

MODULATION OF RNA ACTIVITY AND VASCULAR PERMEABILITY

IPC classification:
A61K 48/00, A61K 31/7088, C12N 15/113, A61P 35/00, A61P 9/00, A61P 7/10
Applicant:
University of Sydney
Agent:
Gevers
Agent:
Elsa Martin-Touaux, Cabinet Orès
Status:
GRANT OF PATENT INTENDED
EP11802949

ROBO1-FC FUSION PROTEIN FOR USE IN THE TREATMENT OF HEPATOCARCINOMA

IPC classification:
A61K 38/18, C07K 14/475
Applicant:
Sanofi, S.A.
Agent:
Elsa Martin-Touaux, Sanofi
Agent:
Gaëlle Jan, Lavoix
Status:
PATENT GRANTED

Please Sign in to use this feature